The TB Alliance established a Scientific Advisory Committee to provide invaluable scientific guidance.
The Scientific Advisory Committee provides technical expertise on drug research, development, manufacturing, and distribution, as well as other medical and scientific issues. It consists of fifteen experts from a wide range of relevant disciplines.
Karin Briner
Novartis
Shefali Kakar
Novartis
Dale Kempf
Distinguished Research Fellow at AbbVie, DNDi
Sarah Merritt Fortune
Harvard School of Public Heath
Carl Nathan
Cornell Medical School
Annalene Nel
International Partnership for Microbicides (IPM)
Eric Nuermberger
Johns Hopkins University
Andrew Nunn
University College London
Jack Reynolds
Anabios
Eric Rubin
Harvard School of Public Health
Rada Savic
University of California, San Francisco
Joyce Sutcliffe
Consultant
Ann Weber
Kallyope Inc.